Why is Mankind Pharma falling/rising?

As of 31-Oct, Mankind Pharma Ltd's stock price is currently at Rs 2,379.30, reflecting a decline of Rs 66.45 or 2.72%. The stock has underperformed its sector today by 2.27% and has experienced a trend reversal, falling after two consecutive days of gains. It touched an intraday low of Rs 2,367.15, which is a decrease of 3.21%. Over the past week, the stock has decreased by 2.15%, and year-to-date, it has fallen by 17.29%. Despite these declines, the company exhibits high management efficiency with a return on equity (ROE) of 17.21%, a low debt-to-EBITDA ratio of 0.69, and strong long-term growth in net sales and operating profit. However, the stock is currently trading below its moving averages, indicating a bearish trend.
In the broader market context, Mankind Pharma's recent performance contrasts with the Sensex, which has increased by 3.65% over the past month. This underperformance is evident as the stock has not only fallen in the short term but also shows a significant decline year-to-date compared to the benchmark's positive return of 7.42%. The rising investor participation, with a delivery volume increase of 19.05%, suggests some interest in the stock despite its recent price drop. The high institutional holdings at 24.76% indicate that knowledgeable investors are involved, which could provide some stability, but the overall market sentiment appears to be weighing on the stock's price.